H
Hendrik Van Poppel
Researcher at Katholieke Universiteit Leuven
Publications - 388
Citations - 23210
Hendrik Van Poppel is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 71, co-authored 367 publications receiving 20611 citations.
Papers
More filters
Journal ArticleDOI
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan,Matthew R. Smith,Johann S. de Bono,Arturo Molina,Christopher J. Logothetis,Paul de Souza,Karim Fizazi,Paul N. Mainwaring,Josep M. Piulats,Siobhan Ng,Joan Carles,Peter F.A. Mulders,Ethan Basch,Eric J. Small,Fred Saad,D. Schrijvers,Hendrik Van Poppel,Som D. Mukherjee,Henrik Suttmann,Winald R. Gerritsen,Thomas W. Flaig,Daniel J. George,Evan Y. Yu,Eleni Efstathiou,Allan J. Pantuck,Eric Winquist,Celestia S. Higano,Mary-Ellen Taplin,Youn C. Park,Thian Kheoh,Thomas W. Griffin,Howard I. Scher,Dana E. Rathkopf +32 more
TL;DR: Abiraterone improved radiographic progression-free survival, showed a trend toward improved overall survival, and significantly delayed clinical decline and initiation of chemotherapy in patients with metastatic castration-resistant prostate cancer.
Journal ArticleDOI
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
Michel Bolla,Hendrik Van Poppel,Laurence Collette,Paul Van Cangh,K. Vekemans,Luigi F. Da Pozzo,Theo M. de Reijke,Antony Verbaeys,Jean-François Bosset,Roland Van Velthoven,Jean-Marie Maréchal,Pierre Scalliet,Karin Haustermans,Marianne Pierart +13 more
TL;DR: Immediate external irradiation after radical prostatectomy improves biochemical progression-free survival and local control in patients with positive surgical margins or pT3 prostate cancer who are at high risk of progression.
Journal ArticleDOI
A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
Hendrik Van Poppel,Luigi F. Da Pozzo,Walter Albrecht,Vsevolod Matveev,Aldo V. Bono,Andrzej Borkowski,Marc Colombel,Laurence Klotz,Eila C. Skinner,Thomas E. Keane,Sandrine Marreaud,Sandra Collette,Richard Sylvester +12 more
TL;DR: NSS for small, easily resectable, incidentally discovered RCC in the presence of a normal contralateral kidney can be performed safely with slightly higher complication rates than after RN.
Journal ArticleDOI
Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Systematic Review and Cumulative Analysis of Comparative Studies
Vincenzo Ficarra,Giacomo Novara,Walter Artibani,Andrea Cestari,Antonio Galfano,Markus Graefen,Giorgio Guazzoni,Bertrand Guillonneau,Mani Menon,Francesco Montorsi,Vipul R. Patel,Jens Rassweiler,Hendrik Van Poppel +12 more
TL;DR: LRP and RALP were more time consuming than RRP, especially in the initial steps of the learning curve, but blood loss, transfusion rates, catheterisation time, hospitalisation duration, and complication rates all favoured LRP, and LRP showed similar continence and potency rates.
Journal ArticleDOI
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.
Matthew R. Smith,Fred Saad,Robert E. Coleman,Neal D. Shore,Karim Fizazi,Bertrand Tombal,Kurt Miller,Paul Sieber,Lawrence Karsh,Ronaldo Damião,Teuvo L.J. Tammela,Blair Egerdie,Hendrik Van Poppel,Joseph L. Chin,Juan Morote,Francisco Gomez-Veiga,Tomasz Borkowski,Zhishen Ye,Amy Kupic,Roger Dansey,Carsten Goessl +20 more
TL;DR: This large randomised study shows that targeting of the bone microenvironment can delay bone metastasis in men with prostate cancer and significantly increased bone-metastasis-free survival.